SAN DIEGO and BRUSSELS–(BUSINESS WIRE)–Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, and the European Organisation for Research and Treatment of Cancer (EORTC) today announced that they will collaborate via EORTC’s Screening Patients for Efficient Clinical Trial Access (SPECTA) biomarker screening initiative to identify patients who harbor a gene rearrangement to NTRK1, NTRK3, ROS1… Read more »
Read what EORTC Director General Denis Lacombe has to say about the scientific complexity and economic cost of developing new cancer therapies, sac à dos kanken fjallraven pas cher nike air max 90 goedkoop which demand a level of collaboration and sharing that takes both industry and academia well beyond their comfort zones,
Over 500 patients in and availability of high quality biological materials SPECTAcolor’s successful start has demonstrated its viability to facilitate next generation cancer clinical trials. Nike Air Max 2017 Heren blauw Nike Air Max 2016 Heren It has been successfully implemented across 21 clinical centers located in nine countries in Europe, has now recruited over… Read more »
Barcelona – The Catalan Institute of Oncology (ICO) today welcomed a party of over 35 delegates from Walgreens Boots Alliance, the first global pharmacy-led health and wellbeing enterprise to showcase the workings of the Screening Patients for Efficient Clinical Trial Access (SPECTAcolor) Biobank of the European Organisation for Research and Treatment of Cancer (EORTC) in… Read more »
Cambridge, UK: 16 November 2015. Chaussures Asics Homme tn requin pas cher 14M Genomics (“14MG”) and The European Organisation for Research and Treatment of Cancer (“EORTC”) today announce the delivery of initial genomic mutation analyses conducted on newly diagnosed cancer patients as part of the EORTC Screening Patients for Efficient Clinical Trial Access (SPECTA) programme…. Read more »
On 22 October 2015, Nike Air Max 1 Heren Nike Air Max TN Femme the SPECTAcolor project investigators met up at the occasion of the bi-annual series of SPECTAcolor Steering Committee meetings to discuss the Biobank project progress. adidas sale uk Air Max Pas Cher This private meeting was held concurrently with the EORTC GITCG… Read more »
SPECTAcolor is the first ever tumour tissue samples biobank and biomarker analysis platform for genetic profiling of patients suffering from advanced colorectal cancer. This platform, Nike Air Max 2016 Dames Zwart unique of its kind joins up research clinical forces at a Pan-European level to develop personalized treatments based on the results of the tissue… Read more »
Hear EORTC Medical Director Dr Vassilis Golfinopoulos talk about the aims of SPECTA (Screening Patients for Efficient Clinical Trial Access) and catch up on other news from 26th EORTC – NCI – AACR symposium on molecular targets in cancer therapeutics in Barcelona.
The second edition of SPECTAforum met its objectives with representation of most of the stakeholders. Nike Air Max Dames Goedkoop With SPECTAcolor, Hollister France the first platform, Goedkoop Adidas Schoenen adidas pas cher now rapidly reaching over 200 patients, SPECTA, nike air max 90 homme pas cher an innovative approach to efficient access to molecular… Read more »
On 19 November 2014, Air Max 2016 Goedkoop nike air max 1 homme the SPECTAcolor project investigators and partners met up at the occasion of the 2nd of the bi-annual series of SPECTAcolor Steering Committee Meetings to discuss the biobank project progress. nike air max pas cher Nike Air Max Sko View the agenda of… Read more »
Walgreens Boots Alliance is supporting SPECTAcolor through fundraising.